Open AccessA rare case of rhino-orbito-maxillary mucormycosis having no common signs and laboratory findings but no visible morbidity
Author(s) -
Aarti Mahesh Khare,
Sachin Tukaram Nemane,
Prashant Shridhar Javade,
Yogesh Pralhad Narkhede,
Punita A. Parti
Publication year - 2021
Publication title -
indian journal of case reports
Language(s) - English
Resource type - Journals
eISSN - 2454-1303
pISSN - 2454-129X
DOI - 10.32677/ijcr.v7i10.3068
Subject(s) - mucormycosis , medicine , surgery , mucorales , amphotericin b , nasal cavity , zygomycosis , dermatology , antifungal
Mucormycosis is an opportunistic fungal infection caused by omnipresent fungi called Mucorales of class Phycomycetes. It mainly occurs in immunocompromised patients, and only early diagnosis with medical and surgical intervention remains the gold standard in managing it. Here, we present the case of a patient contracted with mucormycosis post his COVID-19 infection involving the rhino-orbito-maxillary area. The patient presented to our hospital with dental pain a month after his discharge. Since the mucormycosis cases were at a peak in this period, our team of doctors did a thorough examination of the patient, which revealed dental and ophthalmologic abnormalities. No clinical necrotic eschar in the palatine or nasal cavity was diagnosed, but magnetic resonance imaging (MRI) revealed a typical COVID-19 mucormycosis infection. Accordingly, prompt treatment with systemic amphotericin B was started. However, as the patient declined surgical intervention, we feared the worst outcome, which to our surprise showed no adverse progression.